Abstract
The Ov/Br septin gene, which is also a fusion partner of MLL in acute myeloid leukaemia, is a member of a family of novel GTP binding proteins that have been implicated in cytokinesis and exocytosis. In this study, we describe the genomic and transcriptional organization of this gene, detailing seventeen exons distributed over 240 kb of sequence. Extensive database analyses identified orthologous rodent cDNAs that corresponded to new, unidentified 5′ splice variants of the Ov/Br septin gene, increasing the total number of such variants to six. We report that splicing events, occurring at non-canonical sites within the body of the 3′ terminal exon, remove either 1801 bp or 1849 bp of non-coding sequence and facilitate access to a secondary open reading frame of 44 amino acids maintained near the end of the 3′ UTR. These events constitute a novel coding arrangement and represent the first report of such a design being implemented by a eukaryotic gene. The various Ov/Br proteins either differ minimally at their amino and carboxy termini or are equivalent to truncated versions of larger isoforms. Northern analysis with an Ov/Br septin 3′ UTR probe reveals three transcripts of 4.4, 4 and 3 kb, the latter being restricted to a sub-set of the tissues tested. Investigation of the identified Ov/Br septin isoforms by RT–PCR confirms a complex transcriptional pattern, with several isoforms showing tissue-specific distribution. To date, none of the other human septins have demonstrated such transcriptional complexity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . 1990 J. Mol. Biol. 215: 403–410
Barral Y, Parra M, Bidlingmaier S, Snyder M . 1999 Genes Develop. 13: 176–187
Beites CL, Xie H, Bowser R, Trimble WS . 1999 Nat. Neurosci. 2: 434–439
Bi E, Maddox P, Lew DJ, Salmon ED, McMillan JN, Yeh E, Pringle JR . 1998 J. Cell Biol. 142: 1301–1312
Chant J, Mischke M, Mitchell E, Herskowitz I, Pringle JR . 1995 J. Cell Biol. 129: 767–778
Croft L, Schandorff S, Clark F, Burrage K, Arctander P, Mattick JS . 2000 Nat. Genet. 24: 340–341
DeMarini DJ, Adams AEM, Fares H, DeVirgilio C, Valle G, Chuang JS, Pringle JR . 1997 J. Cell Biol. 139: 75–93
DeVirgilio C, DeMarini DJ, Pringle JR . 1996 Microbiol. 142: 2897–2905
Epp JA, Chant J . 1997 Curr. Biol. 7: 921–929
Fares H, Goetsch L, Pringle JR . 1996 J. Cell Biol. 132: 399–411
Fares HF, Peifer M, Pringle JR . 1995 Mol. Biol. Cell 6: 1843–1859
Field CM, Al-Awar O, Rosenblatt J, Wong ML, Alberts B, Mitchison TJ . 1996 J. Cell Biol. 133: 605–616
Field CM, Kellogg D . 1999 Trends Cell Biol. 9: 387–394
Fung ET, Scheller RH . 1999 FEBS Letters 451: 203–208
Goodison S, Urquidi V, Tarin D . 1999 J. Clin. Path:Mol. Path. 52: 189–196
Hanke J, Brett D, Zastrow I, Aydin A, Delbruck S, Lehmann G, Luft F, Reich J, Bork P . 1999 Trends Genet. 15: 389–390
Hartwell LH . 1971 Exp. Cell Res. 69: 265–276
Hazelrigg T . 1998 95: 451–460
Hsu SC, Hazuka CD, Roth R, Foletti DL, Heuser J, Scheller RH . 1998 Neuron 20: 1111–1122
Kalikin LM, Qu X, Frank TS, Caduff RF, Svoboda SM, Law DJ, Petty EM . 1996 Genes Chrom. Can. 17: 64–68
Kalikin LM, Sims HL, Petty EM . 2000 Genomics 63: 165–172
Kilpatrick GJ, Dautzenberg FM, Martin GR, Eglen RM . 1999 Trends Pharm. Sci. 20: 294–301
Kinoshita M, Kumar S, Mizoguchi A, Ide C, Kinoshita A, Haraguchi T, Hiraoka Y, Noda M . 1997 Genes Develop. 11: 1535–1547
Longtine MS, DeMarini DJ, Valencik ML, Al-Awar OS, Fares H, DeVirgilio C, Pringle JR . 1996 Curr. Opin. Cell Biol. 8: 106–119
Longtine MS, Fares H, Pringle JR . 1998 J. Cell Biol. 143: 719–736
Longtine MS, Theesfeld CL, McMillan JN, Weaver E, Pringle JR, Lew DJ . 2000 Mol. Cell Biol. 20: 4049–4061
Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA . 1998 Proc. Natl. Acad. Sci. USA 95: 6413–6418
Missler M, Sudhof TC . 1998 Trends Genet. 14: 20–26
Mori T, Miura K, Fujiwara T, Shin S, Inazaw J, Nakamura Y . 1996 Cytogenet. Cell Genet. 73: 224–227
Nagase T, Seki N, Ishikawa K, Ohira M, Kawabayashi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N . 1996 DNA Res. 3: 321–329
Neufeld TP, Rubin GM . 1994 Cell 77: 371–379
Osaka M, Rowley JD, Zeleznik-Le NJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6428–6433
Pearson WR . 1990 Methods Enzymol. 183: 63–98
Ross J . 1996 Trends Genet. 12: 171–175
Russell SEH, Hickey GI, Lowry WS, White P, Atkinson RJ . 1990 Oncogene 5: 1581–1583
Russell SEH, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, Keilty GW, Cranston AN, Weissenbach J, Hickey I, Johnston PG . 2000 Cancer Res. 60: 4729–4734
Sambrook J, Fritch EF, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Saraste M, Sibbald PR, Wittinghofer A . 1990 Trends Biochem. Sci. 15: 430–434
Senapathy P, Shapiro MB, Harris NL . 1990 Methods Enzymol. 183: 252–278
Shulewitz MJ, Inouye CJ, Thorner J . 1999 Mol. Cell Biol. 19: 7123–7137
Sorensen AB, Lund AH, Ethelberg S, Copeland NG, Jenkins NA, Pedersen FS . 2000 J. Virol. 74: 2161–2168
Taki T, Ohnishi H, Shinohara K, Sako M, Bessho F, Yanagisawa M, Hayashi Y . 1999 Cancer Res. 59: 4261–4265
Trimble WS . 1999 J. Mem. Biol. 169: 75–81
Xie H, Surka M, Howard J, Trimble WS . 1999 Cell Motil. Cyto. 43: 52–62
Yagi M, Zieger B, Roth GJ, Ware J . 1998 Gene 212: 229–236
Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, Fu G, Zhang QH, Lu L, Tong JH, Gu BW, Yu M, Liu JX, Licht J, Waxman S, Zelent A, Chen E, Chen SJ . 1999 Proc. Natl. Acad. Sci. USA 96: 11422–11427
Acknowledgements
This work is supported by grants from The Cancer Research Campaign, WellBeing and The Ulster Cancer Foundation.
Data deposition
The sequences reported in this paper have been lodged with GenBank.
Accession numbersOv/Br septin γ, [AJ312319]; Ov/Br septin δ, [AJ312320]; Ov/Br septin α, [AJ312321]; Ov/Br septin β, [AJ312322]; Ov/Br septin ε (exon 1ε+2), [AJ312323].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McIlhatton, M., Burrows, J., Donaghy, P. et al. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 20, 5930–5939 (2001). https://doi.org/10.1038/sj.onc.1204752
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204752
Keywords
This article is cited by
-
Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer
Molecular Biology Reports (2023)
-
Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
BMC Gastroenterology (2022)
-
Septins are critical regulators of osteoclastic bone resorption
Scientific Reports (2018)
-
Piccolo paralogs and orthologs display conserved patterns of alternative splicing within the C2A and C2B domains
Genes & Genomics (2016)
-
Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
BMC Cancer (2013)